Zimbabwe adverse events following immunisation surveillance system: A descriptive study with COVID-19 vaccine safety updates. [PDF]
Nyambayo PPM +8 more
europepmc +1 more source
Preclinical development of a well-defined semisynthetic glycoconjugate vaccine against <i>Haemophilus influenzae</i> type b. [PDF]
Han W +9 more
europepmc +1 more source
Correction: Müller et al. Does the Vaccination Against Tick-Borne Encephalitis Offer Good Value for Money for Incidence Rates Below the WHO Threshold for Endemicity? A Case Study for Germany. <i>Vaccines</i> 2024, <i>12</i>, 1165. [PDF]
Müller M +9 more
europepmc +1 more source
Changing Epidemiology of Influenza Infections Among Children in the Post-Pandemic Period: A Case Study in Xi'an, China. [PDF]
Zhao Z +5 more
europepmc +1 more source
Multi-Component Vaccine Candidates Against Non-Typeable <i>Haemophilus influenzae</i>. [PDF]
Belkacem N, Deghmane AE, Taha MK.
europepmc +1 more source
mGem: Progress on the development of conjugate vaccines for <i>Cryptococcus neoformans</i> infections. [PDF]
Stempinski PR +2 more
europepmc +1 more source
Financial risk protection from vaccines in 52 Gavi-eligible low- and middle-income countries: A modeling study. [PDF]
Jiao B +18 more
europepmc +1 more source
A Review of the Effects of Ipsilateral or Contralateral Vaccine Boosting on the Adaptive Immune Response. [PDF]
Naji A, El Sahly HM, Whitaker JA.
europepmc +1 more source
Sociodemographic and Clinical Factors Impact Non-Live Vaccine Coverage After Pediatric Solid Organ Transplantation: A Single Center Study. [PDF]
Blatt AZ, Wang Y, Chang YC, Heston SM.
europepmc +1 more source

